Back to Search
JULIA HALSEY, M.D.
M.D.
Internal Medicine Physician
NPI: 1669767927IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
2011015605(MO)
CMS Specialties
PrimaryINTERNAL MEDICINE
Education
UNIVERSITY OF MISSOURI, COLUMBIA SCHOOL OF MEDICINE
Class of 2011
Research & Publications (20)
Current and future treatment modalities for Clostridium difficile-associated disease.
PMID 18387898·Am J Health Syst Pharm·2008
6-review
Perioperative genomic profiles using structure-specific oligonucleotide probes.
PMID 19474452·Clin Med Res·2009
8-other
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies.
PMID 19299006·Lancet·2009
8-other
Efficacy of intravenous gammaglobulin for immunoglobulin G subclass and/or antibody deficiency in adults.
PMID 19218820·Int Arch Allergy Immunol·2009
3-trial
Assessment of the impact of new UK guidelines on the management of aromatase inhibitor-associated bone loss.
PMID 19043085·Rheumatology (Oxford)·2009
8-other
NICE guidance does not tally with clinical practice--a district general experience.
PMID 18057033·Rheumatology (Oxford)·2008
8-other
A phase II study of gefitinib, 5-fluorouracil, leucovorin, and oxaliplatin in previously untreated patients with metastatic colorectal cancer.
PMID 18981005·Clin Cancer Res·2008
3-trial
Alemtuzumab (Campath-1H) for treatment of refractory polymyositis.
PMID 18843768·J Rheumatol·2008
5-case
Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths.
PMID 18061058·Lancet·2007
1-meta
Survival in relation to angina symptoms and diagnosis among men aged 70-90 years: the Whitehall Study.
PMID 17446808·Eur J Cardiovasc Prev Rehabil·2007
4-observational
Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies.
PMID 16683204·Invest New Drugs·2006
3-trial
Phase II study of gefitinib, fluorouracil, leucovorin, and oxaliplatin therapy in previously treated patients with metastatic colorectal cancer.
PMID 16110021·J Clin Oncol·2005
3-trial
Measurement of cytokine production using whole blood.
PMID 18432956·Curr Protoc Immunol·2005
7-preclinical
Proficiency testing of allergen measurements in residential dust.
PMID 16210059·J Allergy Clin Immunol·2005
7-preclinical
A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer.
PMID 16133798·Invest New Drugs·2005
3-trial
A phase I trial of liposomal doxorubicin, paclitaxel and valspodar (PSC-833), an inhibitor of multidrug resistance.
PMID 16126736·Ann Oncol·2005
3-trial
Referrals to hospital-based rheumatology and orthopaedic services: seeking direction.
PMID 16014409·Rheumatology (Oxford)·2005
4-observational
Can peripheral DXA measurements be used to predict fractures in elderly women living in the community?
PMID 15703863·Osteoporos Int·2005
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 HOSPITAL DR
COLUMBIA, MO 65212 - Phone
- (573) 884-9066
Quick Facts
- NPI
- 1669767927
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 15
- Publications
- 20
Are you this provider?
Claim Your Profile